simendan has been researched along with Ventilator-Associated Pneumonia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boost, KA; Czerwonka, H; Dolfen, A; Hoegl, S; Hofstetter, C; Scheiermann, P; Zwissler, B | 1 |
1 other study(ies) available for simendan and Ventilator-Associated Pneumonia
| Article | Year |
|---|---|
Inhaled levosimendan reduces mortality and release of proinflammatory mediators in a rat model of experimental ventilator-induced lung injury.
Topics: Acid-Base Equilibrium; Administration, Inhalation; Animals; Bronchoalveolar Lavage Fluid; Carbon Dioxide; Cardiotonic Agents; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Hydrazones; Inflammation Mediators; Injections, Intravenous; Interleukin-1beta; Lung; Macrophage Inflammatory Proteins; Macrophages, Alveolar; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Oxygen; Pneumonia, Ventilator-Associated; Pyridazines; Rats; Rats, Wistar; Respiration, Artificial; Simendan; Survival Rate; Vasodilator Agents | 2008 |